Evaluation of the reconstruction osteochondrale lesions of the talus.

Evaluation of the reconstruction osteochondrale lesions of the talus. - Talus-Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

DRKS

Registry ID

DRKS00005175

Enrollment

Registered

2014-01-03

Start date

2013-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteochonrale lesions of the talus.

Interventions

Group 1: Reconstruction with acellular collagenius matrix (CaReS) Group 2: Reconstruction with acellular collagenius membrane (AMIC) Group 3: Reconstruction with debridement and antero- and retrograde

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -osteochndrale lesions of the talus in phase 3 (2) and 4 according to Berndt and Harty with areal damage sizes of 1,5 cm2 -faultless proximity cartilage and bordering hintfoot bones

Exclusion criteria

Exclusion criteria: Patients who not fulfill all inclution criteria - drug or other addiction - women during pregnancy or during breast feeding - patients incapable of contracting - patients with compulsory treatment - psychological diseases with reduced compliance, - chronical diseases of infection - autoimmune diseases - extra risk of bleeding - metabolic arthritis (i.e. gout, pseudo gout) - neurologic diseases (e.g. pareses, neuroparthy)

Design outcomes

Primary

Measure	Time frame
Change in Pain according to VAS in Time for measuring pre-op vs. 12 month post-op.	—

Countries

Germany

Contacts

Public ContactRolf Mickler-Strauch

König-Ludwig-Haus

r-mickler.klh@uni-wuerzburg.de0931-8033120

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026